Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Calidi Biotherapeutics, Inc

Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on February 5
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Proposed Public Offering
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Proposed Public Offering
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board
From Calidi Biotherapeutics, Inc
Via GlobeNewswire
Tickers CLDI
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.